Arvee Laboratories promoters report no share encumbrances in FY26

1 min read     Updated on 16 Jun 2026, 03:41 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Arvee Laboratories (India) Limited disclosed that its promoters and persons acting in concert did not encumber any shares during the financial year ended March 31, 2026, other than those previously declared. The filing was submitted to the National Stock Exchange of India Limited in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. The disclosure included a list of 13 individuals and entities forming the promoter and promoter group.

powered bylight_fuzz_icon
43107078

*this image is generated using AI for illustrative purposes only.

Arvee Laboratories (India) Limited confirmed that its promoters and persons acting in concert did not encumber any shares during the financial year ended March 31, 2026, aside from those already declared. The disclosure, submitted to the National Stock Exchange of India Limited, was made in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. This regulatory requirement mandates the disclosure of any encumbrance on shares held by the promoter group to ensure transparency for shareholders.

The filing, dated April 7, 2026, was signed by Shalin Sudhakarbhai Patel on behalf of the promoters and promoter group. The document explicitly stated that no new encumbrances were created during the year under review. The submission included an annexure listing the names and categories of all individuals and entities comprising the promoter and promoter group.

The promoter group consists of 13 members, including both individuals and Hindu Undivided Families (HUFs). Shalin Sudhakarbhai Patel and Shalin Bharatbhai Chokshi are listed as Promoters, while the remaining members, such as Sudhakar Chhotabhai Patel HUF and Mitaben Bharatbhai Chokshi, are classified under the Promoter Group category.

Promoter and Promoter Group Details

Sr. No Name of Promoter / Promoter Group Category
1 SHALIN SUDHAKARBHAI PATEL Promoter
2 MITABEN BHARATBHAI CHOKSHI Promoter Group
3 SHALIN BHARATBHAI CHOKSHI Promoter
4 SUDHAKAR CHHOTABHAI PATEL HUF Promoter Group
5 SHALINBHAI SUDHAKARBHAI PATEL HUF Promoter Group
6 CHANDRABALABEN PATEL Promoter Group
7 FORUM SAUMIL CHOKSHI Promoter Group
8 KAVITA SHALIN CHOKSHI Promoter Group
9 KHUSHBUBEN SHALINBHAI PATEL Promoter Group
10 BHARAT RASIKLAL CHOKSHI Promoter Group
11 SAUMIL BHARATBHAI CHOKSHI Promoter Group
12 DHAVAL SUNILBHAI THAKKAR Promoter Group
13 VEER SHALIN PATEL Promoter Group

The disclosure provides assurance to the market regarding the financial standing of the company's key shareholders by confirming the absence of additional liens or charges on their holdings during the specified period.

Historical Stock Returns for Arvee Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-1.36%+0.11%+7.52%-35.23%+2.73%+47.33%

How will the market interpret this clean disclosure regarding the promoters' financial health in the context of the company's future capital requirements?

Does the absence of new encumbrances suggest that the promoters are prioritizing retaining ownership over raising personal capital for new ventures?

Could this financial stability of the promoter group position Arvee Laboratories as a more attractive candidate for strategic partnerships or acquisitions?

Arvee Labs FY26 Net Profit Rises to ₹252.63 Lakh

1 min read     Updated on 20 May 2026, 06:17 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Arvee Laboratories (India) Limited reported a net profit of ₹252.63 lakh for FY26, up from ₹214.74 lakh in FY25. Quarterly profit for Q4 stood at ₹52.02 lakh on revenue of ₹1,080.41 lakh. Total assets increased to ₹4,325.71 lakh as of March 31, 2026.

powered bylight_fuzz_icon
40783660

*this image is generated using AI for illustrative purposes only.

Arvee Laboratories (India) Limited has announced its audited financial results for the quarter and year ended March 31, 2026. The Board of Directors approved the financial statements during a meeting held on May 19, 2026. The company reported a net profit of ₹252.63 lakh for the fiscal year 2025-26, marking an increase from ₹214.74 lakh in the previous year.

For the quarter ended March 31, 2026, the company posted a net profit of ₹52.02 lakh. Revenue from operations for the quarter was ₹1,080.41 lakh, while total income stood at ₹1,095.04 lakh. The total expenses for the quarter were reported at ₹1,009.67 lakh.

Financial Performance for FY26

The annual revenue from operations for the year ended March 31, 2026, was recorded at ₹3,151.41 lakh, a decrease from ₹3,848.72 lakh in the prior year. Total income for the year amounted to ₹3,219.52 lakh. The company managed its total expenses effectively, bringing them down to ₹2,976.47 lakh from ₹3,627.36 lakh in the previous fiscal year.

Particulars Year Ended 31/03/2026 (₹ in Lakhs) Year Ended 31/03/2025 (₹ in Lakhs)
Revenue from operations 3,151.41 3,848.72
Total Income 3,219.52 3,914.45
Total Expenses 2,976.47 3,627.36
Profit for the period 252.63 214.74
Earnings per share (Basic) 2.29 1.95

Segment Reporting

The company's operations are primarily divided into Textile and Non-textile segments. For the year ended March 31, 2026, the Non-textile segment contributed significantly to the revenue, reporting ₹2,757.89 lakh, while the Textile segment reported ₹461.63 lakh. The total segment revenue for the year was ₹3,219.52 lakh.

Balance Sheet Highlights

The total assets of the company as of March 31, 2026, stood at ₹4,325.71 lakh, up from ₹3,815.83 lakh in the previous year. The equity and liabilities mirrored this growth, with total equity and liabilities recorded at ₹4,325.71 lakh. The company's paid-up equity share capital remained constant at ₹1,102.00 lakh.

The auditors, M/s. Nirav Patel & Associates, issued an unmodified opinion on the standalone financial results. The board also approved the Statement of Related Party Transactions for the half-year ended March 31, 2026.

Historical Stock Returns for Arvee Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-1.36%+0.11%+7.52%-35.23%+2.73%+47.33%

Given the ~18% decline in annual revenue from operations despite improved profitability, what strategic cost-cutting measures is Arvee Laboratories planning to sustain or improve margins in FY27?

With the Non-textile segment contributing nearly 85% of total segment revenue, is the company considering divesting or scaling down its Textile segment to focus resources on higher-performing operations?

How does Arvee Laboratories plan to deploy the growth in total assets from ₹3,815.83 lakh to ₹4,325.71 lakh to drive revenue recovery in the upcoming fiscal year?

1 Year Returns:+2.73%